Evidence map›Paper›PMID 42590368›Full record

ArticleMaterials (Basel, Switzerland)2026

Effect of Nano-Silver Fluoride Containing 2000 ppm Silver Nanoparticles on the Microhardness and Color of Flowable Resin Composites: An In Vitro Pilot Study.

Emanuel Ewerton Mendonça Vasconcelos, Maria Clara Müller de Andrade, André Galembeck, Gabriela Queiroz de Melo Monteiro, Fernanda Donida Ortigoza, Luís Felipe Espíndola-Castro

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emanuel Ewerton Mendonça VasconcelosFaculty of Dentistry, Federal University of Pernambuco (UFPE), Recife 50670-901, Brazil.ORCID 0009-0004-7481-504X
Maria Clara Müller de AndradeDepartment of Fundamental Chemistry, Federal University of Pernambuco (UFPE), Recife 50670-901, Brazil.ORCID 0000-0001-5727-7658
André GalembeckDepartment of Fundamental Chemistry, Federal University of Pernambuco (UFPE), Recife 50670-901, Brazil.ORCID 0000-0002-6361-9869
Gabriela Queiroz de Melo MonteiroFaculty of Dentistry, University of Pernambuco (UPE), Recife 50040-200, Brazil.ORCID 0000-0001-5616-3405
Fernanda Donida OrtigozaFaculty of Dentistry, Federal University of Pernambuco (UFPE), Recife 50670-901, Brazil.ORCID 0009-0009-6455-3089
Luís Felipe Espíndola-CastroFaculty of Dentistry, Federal University of Pernambuco (UFPE), Recife 50670-901, Brazil.ORCID 0000-0002-1923-8057

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001Fundação de Amparo à Ciência e Tecnologia de Pernambuco APQ-1165-4.02/24
6 · The paper itself

Abstract

Although the modification of resin composites with antimicrobial agents represents a viable alternative for biofilm inhibition, these changes may compromise the optical and mechanical properties of dental restorations. This in vitro pilot study evaluated the effect of incorporating Nano-Silver Fluoride (NSF) containing 2000 ppm silver nanoparticles (AgNPs) on the microhardness and color of flowable resin composites: Vittra APS Unique Flowable (VA), Filtek Bulk Fill Flowable (FB), and Filtek Supreme Flowable (FS). The resin composites were modified by adding 1 wt%, 2 wt%, and 4 wt% NSF and compared with an unmodified group (control). NSF was characterized by UV-visible spectroscopy and transmission electron microscopy. The specimens were subjected to Vickers microhardness testing and color analysis using the CIEDE2000 (ΔE

Indexed as

antimicrobial agentflowable resin compositesnano-silver fluoridesilver nanoparticles

Identifiers

PMID42590368
PMCPMC13468528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.